Strauss joins Gamma Medica's scientific and medical advisory board

William Strauss, MD, clinical chief of Nuclear Medicine at Memorial Sloan Kettering Cancer Center and professor of Radiology at Cornell University's Weill School of Medicine, has been appointed chairman of Gamma Medica Inc.'s Scientific and Medical Advisory Board.

Strauss has held clinical and academic appointments at Boston's Massachusetts General Hospital - Harvard Medical School and at the Stanford University School of Medicine, where he was the chief of the division of Nuclear Medicine. He also previously held the position of VP, Diagnostics Drug Discovery at Bristol-Myers Squibb in Princeton, N.J.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Trimed Popup
Trimed Popup